Fig. 5

Survival analysis of HK3 in glioma. (A) Kaplan‒Meier survival analysis of LGG and GBM in TCGA datasets. In GBM group, the high HK3 expression patients is 77 and low HK3 expression patients is 76. In LGG group, the high HK3 expression patients is 253 and low HK3 expression patients is 252. (B) Time-dependent ROC curve analysis of the efficiency of HK3 expression, patient age at diagnosis, and tumor grade in predicting one-year, three-year, and five-year OS in the TCGA datasets. (C) Univariable and multivariable Cox regression analyses of HK3 expression and several other clinical factors in the TCGA datasets